NF2 and neoplasm: Recent clinical experiences have shown that treatment with bevacizumab resulted in tumor shrinkage and hearing improvement in a subset of patients with NF2 (Plotkin et al., 2009; Mautner et al., 2010; Fujii et al., 2020).